Hatchette Todd F, Drews Steven J, Grudeski Elsie, Booth Tim, Martineau Christine, Dust Kerry, Garceau Richard, Gubbay Jonathan, Karnauchow Tim, Krajden Mel, Levett Paul N, Mazzulli Tony, McDonald Ryan R, McNabb Alan, Mubareka Samira, Needle Robert, Petrich Astrid, Richardson Susan, Rutherford Candy, Smieja Marek, Tellier Raymond, Tipples Graham, LeBlanc Jason J
Division of Microbiology, Department of Pathology and Laboratory Medicine, Capital District Health Authority (CDHA), Dalhousie University, Halifax, Nova Scotia, Canada Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada, University of Alberta, Edmonton, Alberta, Canada.
Provincial Laboratory for Public Health (ProvLab), University of Alberta, Edmonton, Alberta, Canada Department Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
J Clin Microbiol. 2015 May;53(5):1748-51. doi: 10.1128/JCM.03686-14. Epub 2015 Mar 4.
The recent emergence of a severe respiratory disease caused by enterovirus D68 prompted investigation into whether Canadian hospital and provincial laboratories can detect this virus using commercial and laboratory-developed assays. This study demonstrated analytical sensitivity differences between commercial and laboratory-developed assays for the detection of enterovirus D68.
最近由肠道病毒D68引起的一种严重呼吸道疾病的出现,促使人们对加拿大医院和省级实验室能否使用商业检测方法和实验室自行开发的检测方法来检测这种病毒展开调查。这项研究表明了商业检测方法和实验室自行开发的检测方法在检测肠道病毒D68时的分析灵敏度差异。